In-silico drug development for Alzheimer's using 3D disease model

Awaken-Bio's innovative approach leverages a 3D Alzheimer's model to design drugs targeting ECM-driven pathology. By inhibiting PIEZO1, this method aims to reduce inflammation and enhance Aβ clearance, offering a potenti...